Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

A multi-biomarker approach for discrimination of angiographically detected coronary artery disease in metabolic dysfunction-associated steatotic liver disease: the utility of routine laboratory indices

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a globally prevalent chronic liver disease. Accumulating evidence indicates that MASLD is closely linked to coronary artery disease (CAD) through the liver-heart axis, with insulin resistance, chronic systemic inflammation and lipid disorders as...

Zhi-Ying Zhang, Jing-Tao Ma, Jie Huang · 0 citations
Open access Aug 2026

Correlative association between FIB-4 index and graded coronary artery disease severity among MASLD patients: A hypertension-stratified analysis.

BACKGROUND As a highly prevalent metabolic disorder worldwide, MASLD drives atherosclerotic cardiovascular complications through shared inflammatory and metabolic mechanisms collectively termed the liver-heart axis. Metabolic dysfunction-associated fatty liver disease (MASLD, formerly NAFLD) is closely linked to corona...

Zhi-Ying Zhang, Jingtao Ma, Jie Huang · 0 citations
Open access Aug 2026

Exploration of acetylation-related biomarkers in osteoarthritis through bioinformatics analysis

Osteoarthritis (OA) is characterized as a chronic degenerative disorder affecting the joints. A growing body of evidence indicates that acetylation may play a role in the disease’s pathogenesis. However, the underlying molecular mechanisms remain largely undefined. The objective of this study was to explore potential b...

Shu-Chang Li, Jie-Feng Yin, Jie Huang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.